The Owner of Seattle Genetics, Clay Siegall

Clay Siegall is a Scholar who holds a Ph. D and he lead the Seattle Genetics Board since January 2014. In his position as the CEO and Chairman, he leads the company in making critical decisions that will create progress in the enterprise. The company came to his mind in 1997 after he had worked in several companies like Bristol-Myers Squibb Pharmaceutical Research Institute that he worked in for six years and National Cancer Institute where he was in for three years. He also served as a worker in National Institute of Health.

Clay Siegall is a director at Alder BioPharmaceuticals, a company that deals in biotechnology too. In 2013 to 2016, he was a Director of Mirna Therapeutics. He went to school at the University of Maryland where he got a B.S. in Zoology and his Ph. D from the George Washington University. He focuses on health life sciences and has done a lot until he established his company, Seattle Genetics. He has useful skills that together with his leadership skills, has taken him to great heights.

He has blogging sites in which he actively contributes on many topics that are trending. The questions refer to the views of prominent people who make critical decisions for the masses. He has committed to giving the views of leaders on American exit in the Paris Climate Change Agreement and how recycling can add more wastage in the process. He helps readers to expand their knowledge on many things that they need to be updated on. These perspectives and opinions are needed by the people especially when they need to elect new leaders. People can also gauge the thinking of their leaders to see their effectiveness.

With his experience and the various start-ups that he has accomplished, there are inventions that he has come up with that are beneficial to the society. He has made many drugs approved by the FDA. The drugs are antibody type that are thoroughly researched and manufactured by their partners like Bayer, Genentech and Pfizer. His dream is to come up with effective medicines that will heal cancer diseases that have become a predicament worldwide. Since he was young, he has been having a keen interest in medicine.